Update on the management of symptoms in schizophrenia: focus on amisulpride.

about

Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Amisulpride in the treatment of fibromyalgia: an uncontrolled study.

P2860

Q34037969-44BA4BCE-6671-47E7-96B7-2ED8E62CCCAE Q38647035-967AB563-D673-49AD-BB74-065A4190BF9B Q48667612-85735CA8-32E3-4409-BF60-BE7E5603CEE7

P2860

Update on the management of symptoms in schizophrenia: focus on amisulpride.

Item

http://www.wikidata.org/entity/Q41529086

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Update on the management of symptoms in schizophrenia: focus on amisulpride.

@en

type

Item

label

Update on the management of symptoms in schizophrenia: focus on amisulpride.

@en

prefLabel

Update on the management of symptoms in schizophrenia: focus on amisulpride.

@en

P1476

Update on the management of symptoms in schizophrenia: focus on amisulpride.

@en

P2093

Ann M Mortimer

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

The use of amisulpride in the treatment of acute psychosis

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study

Antidepressant-like activity of amisulpride in two animal models of depression

Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators

Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine

Amisulpride: a review of its use in the management of schizophrenia

P304

267-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S3949

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19557121

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

2695215

http://www.w3.org/2001/XMLSchema#string

Update on the management of symptoms in schizophrenia: focus on amisulpride.

about

P2860

P2860

Update on the management of symptoms in schizophrenia: focus on amisulpride.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932